Compounds > itraconazole

itraconazole and Granulocytic Leukemia, Chronic

itraconazole has been researched along with Granulocytic Leukemia, Chronic in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Cheng, G; Huang, L; Li, T; Luo, X; Xue, X; Zhang, Y1
Jagirdar, J; Scott, RS; Sutton, DA1
Huang, M; Liu, WL; Ran, D; Sun, HY; Zhang, YC; Zhou, JF1
Hashinaga, K; Hiramatsu, K; Ishii, H; Iwata, A; Kadota, J; Kishi, K; Kohno, K; Kushima, H; Ogata, M; Ohama, M; Saikawa, T; Tokimatsu, I; Umeki, K1
Fujihara, M; Kyo, T; Myoken, Y; Sugata, T1

Other Studies

5 other study(ies) available for itraconazole and Granulocytic Leukemia, Chronic

ArticleYear
Differential Impacts of Azole Antifungal Drugs on the Pharmacokinetic Profiles of Dasatinib in Rats by LC-MS-MS.
    Current drug metabolism, 2020, Volume: 21, Issue:13

    Topics: Administration, Oral; Animals; Antifungal Agents; Area Under Curve; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dasatinib; Drug Interactions; Drug Monitoring; Humans; Itraconazole; Ketoconazole; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Models, Animal; Protein Kinase Inhibitors; Rats; Tandem Mass Spectrometry; Triazoles; Voriconazole

2020
Lung infection due to opportunistic fungus, Phialemonium obovatum, in a bone marrow transplant recipient: an emerging infection with fungemia and Crohn disease-like involvement of the gastrointestinal tract.
    Annals of diagnostic pathology, 2005, Volume: 9, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Ascomycota; Bone Marrow Transplantation; Drug Resistance, Fungal; Fungemia; Gastrointestinal Diseases; Graft vs Host Disease; Granuloma; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Diseases, Fungal; Male; Middle Aged; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2005
[Ph+ acute lymphoblastic leukemia combined with lung and brain invasive aspergillosis].
    Zhongguo shi yan xue ye xue za zhi, 2006, Volume: 14, Issue:3

    Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Benzamides; Brain Diseases; Humans; Imatinib Mesylate; Itraconazole; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Diseases, Fungal; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines

2006
Invasive pulmonary aspergillosis with hematological malignancy caused by Aspergillus terreus and in vitro susceptibility of A. terreus isolate to micafungin.
    Internal medicine (Tokyo, Japan), 2007, Volume: 46, Issue:11

    Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus; Drug Therapy, Combination; Echinocandins; Humans; Itraconazole; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Male; Micafungin; Neutropenia; Opportunistic Infections; Peptides, Cyclic; Sputum; Stem Cell Transplantation

2007
Oral aspergillosis in compromised patients.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 1996, Volume: 81, Issue:6

    Topics: Adult; Aged; Aspergillosis; Chemoprevention; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Itraconazole; Leukemia, Biphenotypic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lymphoma; Male; Middle Aged; Mouth Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma

1996